摘要
本研究观察了家兔急性心肌梗塞(AMI)早期血浆血小板α-颗粒膜蛋白(GMP-140)、血栓素B_2(TXB_2)、组织型纤溶酶原激活剂(t-pA)及其抑制物(PAL-1)水平的变化及卡托普利干预的影响。结果显示,AMI早期血浆GMP-140浓度、TXB_2浓度、t-pA含量、PAI-1活性均明显升高,t-PA活性显著降低;相关分析表明,血浆GMP-140浓度与PAI-1活性显著正相关。卡托普利干预后,血浆GMP-140浓度、TXB_2浓度、t-PA含量、PAI-1活性均明显降低,而t-PA活性显著增高,心肌梗塞范围缩小。提示,AMI早期纤溶活性降低与血小板活化有关;卡托普利抑制AMI早期血小板活化,改善纤溶活性,可能是其治疗AMI作用机制之一。
hanges of plasma levels of alpha-granule membrane protein 1 40(GMP-140),thromboxaneB_2(TXB_2),tissue-type plasminogen activator(t-pA ),plasminogen activator inhibitor(PAI-1)andthe effect of captopril were studied in the early phase of experimental acute myocardial infarction(AMI)in rabbits by ligation of the left ventricular coronary artery.24 rabbits were equally divid-ed into 3 groups,namely sham operation,AMl and AMI+Captopril.The results showed that inthe early phase of AMI plasma levels of GMP-140,TXB2,t-pA antigen,PAI-1 activity were sig-nificantly elevated,t-pA activity was significantly decreased ,and plasma levels of GMP-140 werecorrelated significantly with plasma PAI-1 activity.Captopril administration significantly de-creased plasma GMP-140, TXB2,t-PA antigen,PAL-1 activity,increased plasma t-PA activity,and reduced myocardial infarct size. The result suggest that decreased fibrinolytic activity in theearly phase of AM I has relation with activation of platelet,and also that captopril can inhibitplatelet activation,improve fibrinolytic activity ,and thus is beneficial to AMI.
出处
《基础医学与临床》
CSCD
1996年第4期297-300,共4页
Basic and Clinical Medicine
关键词
纤溶酶原激活剂
血小板活化
卡托普利
心肌梗塞
tissue-type plasminogen activator activator inhibitor platelet alpha-granule membrane protein captopril acute myocardial infarction